Abpro Corporation Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Abpro Corporation's estimated annual revenue is currently $7.4M per year.(i)
  • Abpro Corporation's estimated revenue per employee is $155,000

Employee Data

  • Abpro Corporation has 48 Employees.(i)
  • Abpro Corporation grew their employee count by 4% last year.

Abpro Corporation's People

NameTitleEmail/Phone
1
CEO and Co-FounderReveal Email/Phone
2
Chairman and Co-FounderReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Associate Director, Antibody DiscoveryReveal Email/Phone
5
Director Corporate DevelopmentReveal Email/Phone
6
Senior Research AssociateReveal Email/Phone
7
Strategic and Operations ManagementReveal Email/Phone
8
Senior Director/Head Nonclinical Research and DevelopmentReveal Email/Phone
9
Senior Research AssociateReveal Email/Phone
10
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Abpro Corporation?

Abpro Corporation is a clinical-stage biotechnology company located in Woburn, Massachusetts. The Company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro's DiversImmuneâ„¢ platform has been used successfully against 300 traditionally difficult targets. The Company has a pipeline of therapies to treat cancer, eye, autoimmune, infectious diseases and other areas. For more information, please visit https://abpro.com/

keywords:N/A

N/A

Total Funding

48

Number of Employees

$7.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.9M4812%N/A
#2
$5.6M4814%N/A
#3
$3.5M4911%N/A
#4
$5.8M50N/AN/A
#5
$9.8M50-17%N/A